CCL2 and Wilson disease: Consistent with reduced hepatic accumulation of toxic lipid intermediates, the hepatic expression of macrophage chemoattractant protein-1 (MCP-1) and pro-inflammatory cytokines and plasma transaminases were either significantly reduced or trended lower in the WD + GSK group (Supplementary Fig. 8a–c).